英文摘要 |
Breast cancer (BC) is the most commonly diagnosed cancer among women. The cause of death of BC is primarily related to cancer metastasis. Mitochondrial calcium uniporter (MCU) complex is a key regulator of the accumulation of mitochondrial calcium. However, the multi-omic understanding of the diagnostic/ prognostic relevance of MCU and its involvement in tumor metastasis remain inconclusive. This study aimed to explore the diagnostic/prognostic significance of MCU and identify the possible mechanisms underlying the BC metastasis. The Cancer Genome Atlas (TCGA) sourced multi-omic analysis was conducted to examine the clinical significance of MCU and its potential mechanisms. The BC tumor showed significantly increased MCU expression levels compared to normal tissue. The high expression of MCU showed no difference among various cancer staging. Higher MCU in BC than in normal tissue was observed in Caucasian and Asian populations, but not in the African population. BC patients with high MCU expression had a shorter survival time than patients with low MCU expression. The prognostic prediction showed statistical significance in the Asian population, grade 3 tumor, Th1-enriched/Th2-decreased tumor. Gene Set Enrichment Analysis (GSEA) identified three core enrichment genes: ITGB1, LOX, and ANTXR1. The proteinprotein interaction (PPI) network showed the enriched functions mainly participate in a protein complex involved in cell adhesion, mitochondrial calcium homeostasis, extracellular matrix organization, and the cell leading edge. In conclusion, this study unveiled the significance of MCU in diagnosis/prognosis in the Asian population and provided mechanistical insights on metastasis-related ECM remodeling. |